Oncology care is increasingly becoming patient centric and the experience of individuals affected by cancer is gaining traction in influencing regulatory authorities, payers and care providers in their decisions. Patient reported outcomes (PROs) are subjective measures that capture these experiences without the interpretation of a healthcare professional. There are significant opportunities with using PROs in both clinical practice and research settings, including the use of PRO to evaluate treatment satisfaction, effectiveness and adherence, as primary or secondary endpoints in clinical trials and to evaluate care delivery. However, the opportunities also pose challenges that need to be overcome, including the limited availability of sufficiently validated instruments, bias related to self-report and recall, burden placed on patients to comply with reporting and a lack of clarity around how authorities can use PRO data in their decisions making.
- Definition of PRO and related terminology, such as PROMS and COA
- PROs routinely used in clinical practice, as well as the opportunities that exist and the challenges that need to be overcome
- Approaches to capture PRO data in clinical trials and research settings, and the related opportunities and challenges
- Value of PRO from regulatory and reimbursement perspectives
Webinar details available here.